
The long-term benefits of antimicrobial use and resistance (AUR) reporting is about improving patient care and combating resistance.
Mok is manager of Pharmacy Services and fellowship director for Clinical Surveillance and Compliance, Wolters Kluwer, Health. He has over a decade of experience in the areas of antimicrobial stewardship, infectious diseases, and clinical pharmacy management. He has practiced in a variety of settings, including government regulatory agencies, academic medical centers and community hospitals. Mok is board-certified in pharmacotherapy and infectious diseases and serves on the Specialty Council on Infectious Diseases of the Board of Pharmacy Specialties to help define the standards of infectious diseases pharmacy practice.
The long-term benefits of antimicrobial use and resistance (AUR) reporting is about improving patient care and combating resistance.
The mandatory reporting of Antimicrobial Use and Resistance (AUR) by hospitals participating in the CMS Medicare Promoting Interoperability Program beginning next year is a important strategy in curbing the overuse of antibiotics.